Cargando…
Best tigecycline dosing for treatment of infections caused by multidrug-resistant pathogens in critically ill patients with different body weights
BACKGROUND: The intensive care unit (ICU) is a center of multidrug-resistant (MDR) pathogens. This is due to overuse of antibiotics in the treatment of critically ill patients. Tigecycline is a broad-spectrum antibiotic that belongs to the glycylcycline group. Tigecycline has been indicated in treat...
Autores principales: | Ibrahim, Mohamed M, Abuelmatty, Abdulla M, Mohamed, Gehan H, Nasr, Mohsen A, Hussein, Amal K, Ebaed, Mohy El Deen, Sarhan, Hatem A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290867/ https://www.ncbi.nlm.nih.gov/pubmed/30584281 http://dx.doi.org/10.2147/DDDT.S181834 |
Ejemplares similares
-
Extended infusion versus intermittent infusion of imipenem in the treatment of ventilator-associated pneumonia
por: Ibrahim, Mohamed M, et al.
Publicado: (2017) -
High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria
por: De Pascale, Gennaro, et al.
Publicado: (2014) -
Global Assessment of the Activity of Tigecycline against Multidrug-Resistant Gram-Negative Pathogens between 2004 and 2014 as Part of the Tigecycline Evaluation and Surveillance Trial
por: Giammanco, Anna, et al.
Publicado: (2017) -
Population pharmacokinetics of tigecycline in critically ill patients
por: Luo, Xiangru, et al.
Publicado: (2023) -
Clinical Outcomes of Tigecycline in the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection
por: Shin, Jung Ar, et al.
Publicado: (2012)